Literature DB >> 25224414

Disease activity and left ventricular structure in patients with rheumatoid arthritis.

Helga Midtbø1, Eva Gerdts2, Tore K Kvien2, Inge C Olsen2, Asle Hirth2, Einar Skulstad Davidsen2, Anne Grete Semb2.   

Abstract

OBJECTIVE: Increased left ventricular (LV) wall thickness/internal diameter ratio (relative wall thickness) was recently reported in RA patients. The aim of this study was to assess the association between LV relative wall thickness and RA disease activity.
METHODS: Clinical and echocardiographic data from 129 RA patients without established cardiovascular disease and 102 controls were used. RA disease activity was assessed by different composite scores and active RA defined by the Simplified Disease Activity Index (SDAI) level exceeding the cut-off for remission (SDAI >3.3).
RESULTS: The RA patients were on average 61.3 years old, 77% were women and 67% had active RA (SDAI >3.3). Patients with active RA had greater LV relative wall thickness and included more patients with treated hypertension (all P < 0.05), but had LV mass index and blood pressure comparable to patients in remission. Having active RA by the SDAI score (β = 0.20, P = 0.008) was also independently associated with greater LV relative wall thickness after adjusting for systolic blood pressure, wall stress, age and sex in a multivariate model. This association was robust also in secondary models including other disease activity composite scores such as the Clinical Disease Activity Index and 28-joint DAS.
CONCLUSION: Among RA patients, higher disease activity was independently associated with greater LV relative wall thickness, reflecting subclinical heart disease. The findings point to the importance of disease activity control in RA patients to prevent progression to clinical heart disease.
© The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  cardiovascular disease; disease activity; hypertension; rheumatoid arthritis

Mesh:

Year:  2014        PMID: 25224414     DOI: 10.1093/rheumatology/keu368

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  8 in total

Review 1.  Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications.

Authors:  Bryant R England; Geoffrey M Thiele; Daniel R Anderson; Ted R Mikuls
Journal:  BMJ       Date:  2018-04-23

Review 2.  Echocardiography in the Assessment of Patients with Rheumatologic Diseases.

Authors:  Maha A Al-Mohaissen; Kwan-Leung Chan
Journal:  Curr Cardiol Rep       Date:  2016-08       Impact factor: 2.931

3.  High prevalence of occult heart disease in normotensive patients with rheumatoid arthritis.

Authors:  Giovanni Cioffi; Federica Ognibeni; Andrea Dalbeni; Alessandro Giollo; Giovanni Orsolini; Davide Gatti; Maurizio Rossini; Ombretta Viapiana
Journal:  Clin Cardiol       Date:  2018-06-05       Impact factor: 2.882

4.  Preclinical cardiac organ damage during statin treatment in patients with inflammatory joint diseases: the RORA-AS statin intervention study.

Authors:  Hanna A Os; Silvia Rollefstad; Eva Gerdts; Ester Kringeland; Eirik Ikdahl; Anne Grete Semb; Helga Midtbø
Journal:  Rheumatology (Oxford)       Date:  2020-12-01       Impact factor: 7.580

5.  Biomarkers of inflammation and left ventricular remodelling in psoriasis patients treated with infliximab.

Authors:  Helga Midtbø; Ester Kringeland; Eva Gerdts; Per Magne Ueland; Klaus Meyer; Anja Linde; Arve Ulvik; Roland Jonsson; Kåre Steinar Tveit
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.298

6.  Subclinical Cardiac Organ Damage in Patients with Moderate to Severe Psoriasis.

Authors:  Anja Linde; Eva Gerdts; Kåre Steinar Tveit; Ester Kringeland; Helga Midtbø
Journal:  J Clin Med       Date:  2021-05-31       Impact factor: 4.241

7.  Features of cardiac remodeling in Patients with Acute Coronary Syndrome Complicated with Rheumatoid Arthritis.

Authors:  Lili Pan; Tian Wang
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

8.  Anti-modified citrullinated vimentin antibody: a novel biomarker associated with cardiac systolic dysfunction in patients with rheumatoid arthritis.

Authors:  Somayye Norouzi; Ali Javinani; Arya Aminorroaya; Maryam Masoumi
Journal:  BMC Cardiovasc Disord       Date:  2020-08-26       Impact factor: 2.298

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.